Bavarian Nordic, Johnson & Johnson join forces to develop HIV, HBV shots in $879M deal
admin 27th July 2017 Uncategorised 0It’s clear now that HIV and hep B are two infectious disease targets J&J kept mum about when it expanded a vaccine deal with Bavarian Nordic in 2015. The two just partnered up on those two prospects in a deal worth up to $879 million.
More: Bavarian Nordic, Johnson & Johnson join forces to develop HIV, HBV shots in 9M deal
Source: fierce